Keyuan Industry Fund logo

Keyuan Industry Fund

Asia, Beijing, China, Beijing

Description

Keyuan Industry Fund is a fund manager that focuses on integrating technological innovation, financial support, and industrial resources.

Investor Profile

Keyuan Industry Fund has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Manufacturing, Biopharma.

Stage Focus

  • Series C (50%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Genetics
  • Life Science
  • Recycling
  • Chemical
  • Cleantech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Keyuan Industry Fund frequently co-invest with?

GB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Maison Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Zero2IPO
Asia, Beijing, China, Beijing
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Keyuan Industry Fund?

Phase Two Chemicals

Lowell, Massachusetts, United States

Phase Two Chemicals is a clean chemistry company developing breakthrough technology for on-site hydrogen peroxide production.

ChemicalCleanTechManufacturing
Series AJan 1, 2022
Amount Raised: $12,000,000
Abogen Biosciences

Suzhou, Jiangsu, China

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

BiotechnologyGeneticsLife Science
Series CNov 29, 2021
Amount Raised: $300,000,000
ESSE

Beijing, Beijing, China

ESSE specializes in the production of environmentally functional materials using industrial solid waste recycling technology.

ManufacturingRecycling
Series UnknownNov 1, 2021
Elpiscience Biopharmaceuticals

Shanghai, Shanghai, China

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CMay 13, 2021
Amount Raised: $105,000,000